Articles Tagged with ''Daily International Pharma Alert''

Eli Lilly Increases Investment in TB Fight

Drugmaker Eli Lilly, in conjunction with World Tuberculosis (TB) Day, has announced plans to invest an additional $50 million in a global partnership to fight multidrug-resistant tuberculosis (MDR-TB).

Read More

CDC Issues Final Guidelines on Gardasil

The U.S. Centers for Disease Control and Prevention (CDC) has adopted the recommendation of its Advisory Committee on Immunization Practices for the use of Merck's Gardasil quadrivalent human papillomavirus (HPV) vaccine in girls and women ages 11 to 26, Merck announced.

Read More

EMEA Finds Tamiflu Benefits Outweigh Risks

The European Medicines Agency (EMEA) has issued a statement on the safety of Tamiflu in response to news of neuropsychiatric adverse events reported in connection with the drug in Japan.

Read More

PEPFAR to Increase Response to HIV, TB Co-Infection

In advance of World Tuberculosis (TB) Day later this week, the President's Emergency Plan for AIDS Relief (PEPFAR) announced it is planning to increase its response to tuberculosis globally by supporting programs that integrate HIV prevention, treatment and care with TB services.

Read More

Canadian Industry Group Calls for Increase in Generic Drug Use

In one year Canadians could save $700 million on the cost of prescription drugs if the use of generic drugs were increased to U.S. levels, the Canadian Generic Pharmaceutical Association (CGPA) said in response to the 2006 Canadian prescription drug sales data released by IMS Health.

Read More

NEW GENERIC HIV DRUG AVAILABLE FOR PEPFAR USE

The U.S. FDA announced it has granted tentative approval to generic lamivudine tablets, 150 mg, manufactured by Matrix Laboratories under expedited-review provisions developed for the President's Emergency Plan for AIDS Relief (PEPFAR).

Read More

PFIZER WINS CELEBREX PATENT CHALLENGE

Pfizer announced yesterday that a federal court in New Jersey has upheld the company's three main U.S. patents covering Celebrex, a selective non-steroidal anti-inflammatory drug used to treat pain and inflammation.

Read More